SCHEMBL4017879

SCHEMBL4017879

CN(CCF)c1ccc(-c2ccc3nonc3c2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
APP P05067 7/20 0.43
BRAF P15056 1/20 0.36
MAPT P10636 2/20 0.35
SNCA P37840 2/20 0.35
ENPP2 Q13822 2/20 0.35
KDM4E B2RXH2 1/20 0.34
KCNH2 Q12809 1/20 0.34
TDO2 P48775 1/20 0.34
PIK3CD O00329 1/20 0.33
ALDH1A1 P00352 2/20 0.33
TGFBR1 P36897 1/20 0.33
MEN1 O00255 1/20 0.33
LMNA P02545 1/20 0.33
TP53 P04637 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
MAPK1 P28482 1/20 0.33
CASP1 P29466 1/20 0.33
CASP7 P55210 1/20 0.33
KMT2A Q03164 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4499060 0.79 CYP1A2 (0.49) APPMAPTENPP2KDM4ETDO2
SCHEMBL3303268 0.73 FFAR1 (0.42) APPBRAFMAPTSNCATGFBR1
SCHEMBL3078778 0.73 ENPP2 (0.58) ENPP2KDM4EKCNH2TDO2PIK3CD
SCHEMBL20004343 0.72 APP (0.49) APPMAPTSNCAALDH1A1
SCHEMBL4017508 0.71 ADORA3 (0.40) MAPTENPP2ALDH1A1
SCHEMBL4017940 0.70 MAPT (0.44) APPMAPTENPP2PIK3CD
SCHEMBL4015933 0.69 NOTUM (0.46) MAPTENPP2KDM4ETDO2ALDH1A1
SCHEMBL21146821 0.68 APP (0.46) APPMAPTSNCA
SCHEMBL23143419 0.67 ENPP2 (0.47) MAPTENPP2TDO2PIK3CDTGFBR1
SCHEMBL28897577 0.67 ENPP2 (0.47) ENPP2KCNH2TDO2PIK3CDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1613610-B1 BENZO 1,2,5 OXADIAZOLES AND BENZO 1,2,5 THIADIAZOLES USEFUL AS HISTOPATHOLOGICAL STAINING AGENTS, IMAGING AGENTS AND BIOMARKERS NOVARTIS AG (CH) 2009-07-01 EP disclosed